Annual CFO
-$53.24 M
+$46.90 M+46.83%
31 December 2023
Summary:
Talis Biomedical annual cash flow from operations is currently -$53.24 million, with the most recent change of +$46.90 million (+46.83%) on 31 December 2023. During the last 3 years, it has risen by +$118.14 million (+68.94%). TLIS annual CFO is now -154.21% below its all-time high of -$20.94 million, reached on 31 December 2018.TLIS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$11.33 M
-$4.90 M-76.29%
30 June 2024
Summary:
Talis Biomedical quarterly cash flow from operations is currently -$11.33 million, with the most recent change of -$4.90 million (-76.29%) on 30 June 2024. Over the past year, it has increased by +$27.00 thousand (+0.24%). TLIS quarterly CFO is now -102.97% below its all-time high of -$5.58 million, reached on 31 March 2020.TLIS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$40.26 M
+$2.94 M+6.81%
30 June 2024
Summary:
Talis Biomedical TTM cash flow from operations is currently -$40.26 million, with the most recent change of +$2.94 million (+6.81%) on 30 June 2024. Over the past year, it has increased by +$12.98 million (+24.38%). TLIS TTM CFO is now -621.21% below its all-time high of -$5.58 million, reached on 31 March 2020.TLIS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TLIS Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +0.2% | +24.4% |
| 3 y3 years | +68.9% | +72.2% | +76.5% |
| 5 y5 years | -118.9% | - | - |
TLIS Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +68.9% | -76.3% | +84.8% | at high | +79.1% |
| 5 y | 5 years | -154.2% | +68.9% | -103.0% | +84.8% | -621.2% | +79.1% |
| alltime | all time | -154.2% | +68.9% | -103.0% | +84.8% | -621.2% | +79.1% |
Talis Biomedical Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$11.33 M(+76.3%) | -$40.26 M(-6.8%) |
| Mar 2024 | - | -$6.43 M(-43.4%) | -$43.20 M(-18.9%) |
| Dec 2023 | -$53.24 M(-46.8%) | -$11.36 M(+1.9%) | -$53.24 M(-3.9%) |
| Sept 2023 | - | -$11.14 M(-21.9%) | -$55.43 M(-14.9%) |
| June 2023 | - | -$14.27 M(-13.3%) | -$65.10 M(-10.6%) |
| Mar 2023 | - | -$16.46 M(+21.6%) | -$72.84 M(-27.3%) |
| Dec 2022 | -$100.14 M(-41.6%) | -$13.54 M(-35.0%) | -$100.14 M(-21.4%) |
| Sept 2022 | - | -$20.82 M(-5.4%) | -$127.33 M(-29.8%) |
| June 2022 | - | -$22.01 M(-49.7%) | -$181.26 M(-5.9%) |
| Mar 2022 | - | -$43.76 M(+7.4%) | -$192.66 M(+12.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$171.38 M(+96.9%) | -$40.74 M(-45.5%) | -$171.38 M(+2.4%) |
| Sept 2021 | - | -$74.75 M(+123.7%) | -$167.33 M(+33.5%) |
| June 2021 | - | -$33.41 M(+48.6%) | -$125.38 M(+20.6%) |
| Mar 2021 | - | -$22.48 M(-38.7%) | -$103.93 M(+19.4%) |
| Dec 2020 | -$87.02 M(+257.7%) | -$36.69 M(+11.9%) | -$87.02 M(+72.9%) |
| Sept 2020 | - | -$32.80 M(+174.4%) | -$50.33 M(+187.0%) |
| June 2020 | - | -$11.95 M(+114.1%) | -$17.54 M(+214.1%) |
| Mar 2020 | - | -$5.58 M | -$5.58 M |
| Dec 2019 | -$24.33 M(+16.2%) | - | - |
| Dec 2018 | -$20.94 M | - | - |
FAQ
- What is Talis Biomedical annual cash flow from operations?
- What is the all time high annual CFO for Talis Biomedical?
- What is Talis Biomedical quarterly cash flow from operations?
- What is the all time high quarterly CFO for Talis Biomedical?
- What is Talis Biomedical quarterly CFO year-on-year change?
- What is Talis Biomedical TTM cash flow from operations?
- What is the all time high TTM CFO for Talis Biomedical?
- What is Talis Biomedical TTM CFO year-on-year change?
What is Talis Biomedical annual cash flow from operations?
The current annual CFO of TLIS is -$53.24 M
What is the all time high annual CFO for Talis Biomedical?
Talis Biomedical all-time high annual cash flow from operations is -$20.94 M
What is Talis Biomedical quarterly cash flow from operations?
The current quarterly CFO of TLIS is -$11.33 M
What is the all time high quarterly CFO for Talis Biomedical?
Talis Biomedical all-time high quarterly cash flow from operations is -$5.58 M
What is Talis Biomedical quarterly CFO year-on-year change?
Over the past year, TLIS quarterly cash flow from operations has changed by +$27.00 K (+0.24%)
What is Talis Biomedical TTM cash flow from operations?
The current TTM CFO of TLIS is -$40.26 M
What is the all time high TTM CFO for Talis Biomedical?
Talis Biomedical all-time high TTM cash flow from operations is -$5.58 M
What is Talis Biomedical TTM CFO year-on-year change?
Over the past year, TLIS TTM cash flow from operations has changed by +$12.98 M (+24.38%)